The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

PAP and Paracetamol-Global Market Insights and Sales Trends 2024

PAP and Paracetamol-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1859638

No of Pages : 114

Synopsis
Paracetamol, also named acetaminophen, is an active ingredient in hundreds of over-the-counter (OTC) and prescription medicines. It relieves pain and fever. And, it is also combined with other active ingredients in medicines that treat allergy, cough, colds, flu, and sleeplessness.
The global PAP and Paracetamol market size is expected to reach US$ 977.5 million by 2029, growing at a CAGR of 2.0% from 2023 to 2029. The market is mainly driven by the significant applications of PAP and Paracetamol in various end use industries. The expanding demands from the Tablet Drug, Granules Drug, Oral Solution and Others, are propelling PAP and Paracetamol market. Powder, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Granules segment is estimated at % CAGR for the next seven-year period.
In the world the production of paracetamol is highly concentrated in China and India, the two countries occupy about 83.86% of the global production (China 59.02% and India 24.84%) in 2017, and their market share has been increasing in recent years.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for PAP and Paracetamol, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global PAP and Paracetamol market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global PAP and Paracetamol market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, PAP and Paracetamol sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of PAP and Paracetamol covered in this report include Mallinckrodt, Anqiu Lu'an, Granules India, Zhejiang Kangle, Farmson, Hebei Jiheng, Novacyl, Anhui BBCA Likang and Anhui Fubore, etc.
The global PAP and Paracetamol market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Mallinckrodt
Anqiu Lu'an
Granules India
Zhejiang Kangle
Farmson
Hebei Jiheng
Novacyl
Anhui BBCA Likang
Anhui Fubore
SKPL
Atabay
Huzhou Konch
Changshu Huagang
Anhui Topsun
Sino Chemical
Global PAP and Paracetamol market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global PAP and Paracetamol market, Segment by Type:
Powder
Granules
Global PAP and Paracetamol market, by Application
Tablet Drug
Granules Drug
Oral Solution
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of PAP and Paracetamol companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of PAP and Paracetamol
1.1 PAP and Paracetamol Market Overview
1.1.1 PAP and Paracetamol Product Scope
1.1.2 PAP and Paracetamol Market Status and Outlook
1.2 Global PAP and Paracetamol Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global PAP and Paracetamol Market Size by Region (2018-2029)
1.4 Global PAP and Paracetamol Historic Market Size by Region (2018-2023)
1.5 Global PAP and Paracetamol Market Size Forecast by Region (2024-2029)
1.6 Key Regions, PAP and Paracetamol Market Size (2018-2029)
1.6.1 North America PAP and Paracetamol Market Size (2018-2029)
1.6.2 Europe PAP and Paracetamol Market Size (2018-2029)
1.6.3 Asia-Pacific PAP and Paracetamol Market Size (2018-2029)
1.6.4 Latin America PAP and Paracetamol Market Size (2018-2029)
1.6.5 Middle East & Africa PAP and Paracetamol Market Size (2018-2029)
2 PAP and Paracetamol Market by Type
2.1 Introduction
2.1.1 Powder
2.1.2 Granules
2.2 Global PAP and Paracetamol Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global PAP and Paracetamol Historic Market Size by Type (2018-2023)
2.2.2 Global PAP and Paracetamol Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America PAP and Paracetamol Revenue Breakdown by Type (2018-2029)
2.3.2 Europe PAP and Paracetamol Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific PAP and Paracetamol Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America PAP and Paracetamol Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa PAP and Paracetamol Revenue Breakdown by Type (2018-2029)
3 PAP and Paracetamol Market Overview by Application
3.1 Introduction
3.1.1 Tablet Drug
3.1.2 Granules Drug
3.1.3 Oral Solution
3.1.4 Others
3.2 Global PAP and Paracetamol Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global PAP and Paracetamol Historic Market Size by Application (2018-2023)
3.2.2 Global PAP and Paracetamol Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America PAP and Paracetamol Revenue Breakdown by Application (2018-2029)
3.3.2 Europe PAP and Paracetamol Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific PAP and Paracetamol Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America PAP and Paracetamol Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa PAP and Paracetamol Revenue Breakdown by Application (2018-2029)
4 PAP and Paracetamol Competition Analysis by Players
4.1 Global PAP and Paracetamol Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in PAP and Paracetamol as of 2022)
4.3 Date of Key Players Enter into PAP and Paracetamol Market
4.4 Global Top Players PAP and Paracetamol Headquarters and Area Served
4.5 Key Players PAP and Paracetamol Product Solution and Service
4.6 Competitive Status
4.6.1 PAP and Paracetamol Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Mallinckrodt
5.1.1 Mallinckrodt Profile
5.1.2 Mallinckrodt Main Business
5.1.3 Mallinckrodt PAP and Paracetamol Products, Services and Solutions
5.1.4 Mallinckrodt PAP and Paracetamol Revenue (US$ Million) & (2018-2023)
5.1.5 Mallinckrodt Recent Developments
5.2 Anqiu Lu'an
5.2.1 Anqiu Lu'an Profile
5.2.2 Anqiu Lu'an Main Business
5.2.3 Anqiu Lu'an PAP and Paracetamol Products, Services and Solutions
5.2.4 Anqiu Lu'an PAP and Paracetamol Revenue (US$ Million) & (2018-2023)
5.2.5 Anqiu Lu'an Recent Developments
5.3 Granules India
5.3.1 Granules India Profile
5.3.2 Granules India Main Business
5.3.3 Granules India PAP and Paracetamol Products, Services and Solutions
5.3.4 Granules India PAP and Paracetamol Revenue (US$ Million) & (2018-2023)
5.3.5 Zhejiang Kangle Recent Developments
5.4 Zhejiang Kangle
5.4.1 Zhejiang Kangle Profile
5.4.2 Zhejiang Kangle Main Business
5.4.3 Zhejiang Kangle PAP and Paracetamol Products, Services and Solutions
5.4.4 Zhejiang Kangle PAP and Paracetamol Revenue (US$ Million) & (2018-2023)
5.4.5 Zhejiang Kangle Recent Developments
5.5 Farmson
5.5.1 Farmson Profile
5.5.2 Farmson Main Business
5.5.3 Farmson PAP and Paracetamol Products, Services and Solutions
5.5.4 Farmson PAP and Paracetamol Revenue (US$ Million) & (2018-2023)
5.5.5 Farmson Recent Developments
5.6 Hebei Jiheng
5.6.1 Hebei Jiheng Profile
5.6.2 Hebei Jiheng Main Business
5.6.3 Hebei Jiheng PAP and Paracetamol Products, Services and Solutions
5.6.4 Hebei Jiheng PAP and Paracetamol Revenue (US$ Million) & (2018-2023)
5.6.5 Hebei Jiheng Recent Developments
5.7 Novacyl
5.7.1 Novacyl Profile
5.7.2 Novacyl Main Business
5.7.3 Novacyl PAP and Paracetamol Products, Services and Solutions
5.7.4 Novacyl PAP and Paracetamol Revenue (US$ Million) & (2018-2023)
5.7.5 Novacyl Recent Developments
5.8 Anhui BBCA Likang
5.8.1 Anhui BBCA Likang Profile
5.8.2 Anhui BBCA Likang Main Business
5.8.3 Anhui BBCA Likang PAP and Paracetamol Products, Services and Solutions
5.8.4 Anhui BBCA Likang PAP and Paracetamol Revenue (US$ Million) & (2018-2023)
5.8.5 Anhui BBCA Likang Recent Developments
5.9 Anhui Fubore
5.9.1 Anhui Fubore Profile
5.9.2 Anhui Fubore Main Business
5.9.3 Anhui Fubore PAP and Paracetamol Products, Services and Solutions
5.9.4 Anhui Fubore PAP and Paracetamol Revenue (US$ Million) & (2018-2023)
5.9.5 Anhui Fubore Recent Developments
5.10 SKPL
5.10.1 SKPL Profile
5.10.2 SKPL Main Business
5.10.3 SKPL PAP and Paracetamol Products, Services and Solutions
5.10.4 SKPL PAP and Paracetamol Revenue (US$ Million) & (2018-2023)
5.10.5 SKPL Recent Developments
5.11 Atabay
5.11.1 Atabay Profile
5.11.2 Atabay Main Business
5.11.3 Atabay PAP and Paracetamol Products, Services and Solutions
5.11.4 Atabay PAP and Paracetamol Revenue (US$ Million) & (2018-2023)
5.11.5 Atabay Recent Developments
5.12 Huzhou Konch
5.12.1 Huzhou Konch Profile
5.12.2 Huzhou Konch Main Business
5.12.3 Huzhou Konch PAP and Paracetamol Products, Services and Solutions
5.12.4 Huzhou Konch PAP and Paracetamol Revenue (US$ Million) & (2018-2023)
5.12.5 Huzhou Konch Recent Developments
5.13 Changshu Huagang
5.13.1 Changshu Huagang Profile
5.13.2 Changshu Huagang Main Business
5.13.3 Changshu Huagang PAP and Paracetamol Products, Services and Solutions
5.13.4 Changshu Huagang PAP and Paracetamol Revenue (US$ Million) & (2018-2023)
5.13.5 Changshu Huagang Recent Developments
5.14 Anhui Topsun
5.14.1 Anhui Topsun Profile
5.14.2 Anhui Topsun Main Business
5.14.3 Anhui Topsun PAP and Paracetamol Products, Services and Solutions
5.14.4 Anhui Topsun PAP and Paracetamol Revenue (US$ Million) & (2018-2023)
5.14.5 Anhui Topsun Recent Developments
5.15 Sino Chemical
5.15.1 Sino Chemical Profile
5.15.2 Sino Chemical Main Business
5.15.3 Sino Chemical PAP and Paracetamol Products, Services and Solutions
5.15.4 Sino Chemical PAP and Paracetamol Revenue (US$ Million) & (2018-2023)
5.15.5 Sino Chemical Recent Developments
6 North America
6.1 North America PAP and Paracetamol Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe PAP and Paracetamol Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific PAP and Paracetamol Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America PAP and Paracetamol Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa PAP and Paracetamol Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 PAP and Paracetamol Market Dynamics
11.1 PAP and Paracetamol Industry Trends
11.2 PAP and Paracetamol Market Drivers
11.3 PAP and Paracetamol Market Challenges
11.4 PAP and Paracetamol Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’